Asymmetry Capital Management
Zarak Khurshid, joined Asymmetry in 2016. He covers all non-therapeutic healthcare sectors, which includes medical technology, devices, tools, diagnostics, labs, healthcare IT and services. Previously, Zarak worked as the Senior Vice President of Equity Research at Wedbush Securities PacGrowth Life Sciences, Caris & Company and as a Research Analyst at Pacific Growth Equities, LLC. He began his career in industry, working for Aurora Biosciences and Cytokinetics Inc.
Zarak received his B.A. in Economics and B.S. in Bioengineering from the University of California, San Diego.
This person is not in any offices
Asymmetry Capital Management
Asymmetry Capital Management, L.P. invests in global healthcare and healthcare related companies using a long/short strategy. They invest across all healthcare sectors with a focus on Pharmaceuticals, Specialty Pharmaceuticals, Biotechnology, Medical Devices and Healthcare Services.